Ethan Lazarus, MD, MFOMA Clinical Nutrition Center Greenwood Village, CO (303) 750-9454
Patient autonomy & plan choice Mochi: Shared decision-making with a provider on the specific GLP-1 path (including compounded options when appropriate), with room to adjust over time
FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Finally, encourage patients to report any persistent neck masses, hoarseness, or swallowing difficulties
But the goal was never just to make the number on the scale go down
In under an hour, youll go from wiped out to wide awake no greasy food or guesswork required.Feel Better, Faster Because Last Night Shouldnt Ruin Today